Otsuka Pakistan's earnings have been declining at an average annual rate of -9.4%, while the Pharmaceuticals industry saw earnings growing at 3.4% annually. Revenues have been growing at an average rate of 8.9% per year.
Key information
-9.4%
Earnings growth rate
-9.4%
EPS growth rate
Pharmaceuticals Industry Growth
20.2%
Revenue growth rate
8.9%
Return on equity
-28.8%
Net Margin
-5.0%
Last Earnings Update
30 Sep 2024
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Otsuka Pakistan makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
KASE:OTSU Revenue, expenses and earnings (PKR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Sep 24
3,179
-160
617
0
30 Jun 24
3,164
-5
590
0
31 Mar 24
2,828
84
499
0
31 Dec 23
3,014
37
493
0
30 Sep 23
3,127
51
496
0
30 Jun 23
3,035
-7
497
0
31 Mar 23
3,104
-40
504
0
31 Dec 22
3,013
87
496
0
30 Sep 22
2,829
136
495
0
30 Jun 22
2,852
232
483
0
31 Mar 22
2,894
397
439
0
31 Dec 21
2,822
423
420
0
30 Sep 21
2,661
418
396
0
30 Jun 21
2,546
386
385
0
31 Mar 21
2,392
235
370
0
31 Dec 20
2,308
145
360
0
30 Sep 20
2,304
109
360
0
30 Jun 20
2,227
91
365
0
31 Mar 20
2,124
-49
373
0
31 Dec 19
2,094
-49
373
0
30 Sep 19
1,977
-153
365
0
30 Jun 19
1,885
-175
348
0
31 Mar 19
1,911
-49
358
0
31 Dec 18
1,872
-46
349
0
30 Sep 18
1,805
32
334
0
30 Jun 18
1,869
65
321
0
31 Mar 18
1,888
65
299
0
31 Dec 17
1,884
82
291
0
30 Sep 17
1,907
138
296
0
30 Jun 17
1,830
110
289
0
31 Mar 17
1,755
95
286
0
31 Dec 16
1,726
29
279
0
30 Sep 16
1,634
-58
262
0
30 Jun 16
1,551
-112
256
0
31 Mar 16
1,482
-173
254
0
31 Dec 15
1,447
-164
256
0
30 Sep 15
1,424
-132
256
0
30 Jun 15
1,452
-146
254
0
31 Mar 15
1,328
-130
238
0
31 Dec 14
1,175
-170
230
0
30 Sep 14
1,134
-219
221
0
30 Jun 14
1,078
-200
221
0
31 Mar 14
1,125
-190
225
0
31 Dec 13
1,169
-116
231
0
Quality Earnings: OTSU is currently unprofitable.
Growing Profit Margin: OTSU is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OTSU is unprofitable, and losses have increased over the past 5 years at a rate of 9.4% per year.
Accelerating Growth: Unable to compare OTSU's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OTSU is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (56%).
Return on Equity
High ROE: OTSU has a negative Return on Equity (-28.84%), as it is currently unprofitable.